Adeyemo Samuel, Jegede Oluwole, Rabel Peterson, Ahmed Saad, Tumenta Terence, Oladeji Oluwatoyin, Taher Khanderker
Department of Psychiatry, Interfaith Medical Center, 1545 Atlantic Avenue, Brooklyn, New York, USA.
Case Rep Psychiatry. 2020 Jul 6;2020:6352175. doi: 10.1155/2020/6352175. eCollection 2020.
Tachycardia emergent from clozapine treatment is usually transient, often missed, unreported, and therefore frequently goes untreated resulting in possible premature discontinuation of an otherwise effective treatment. Clozapine-induced tachycardia results from direct effects on the sympathetic nervous system including the blockade of cardiac muscarinic M receptors, presynaptic adrenoceptors, and indirect activation of the adrenoceptors. Unfortunately, there are no clear guidelines for monitoring or treating tachycardia induced by clozapine. We present a case of a 55-year-old man with treatment-resistant schizophrenia initiated on clozapine who developed persistent tachycardia and right bundle branch block in the course of treatment. Tachycardia persisted despite treatment with metoprolol and necessitated a transfer to the intensive care unit. A reduction in clozapine dose with the addition of adjunctive antipsychotic(lurasidone) stabilized the patient's heart rate. This case highlights the need for consistent physical examination and a multidisciplinary-based treatment approach for patients on clozapine. The case also suggests that clozapine dose reduction and combination antipsychotic treatments may preclude the need to discontinue clozapine in patients with persistent tachycardia.
氯氮平治疗过程中出现的心动过速通常是短暂的,常常被漏诊、未报告,因此常常得不到治疗,可能导致原本有效的治疗过早中断。氯氮平所致心动过速是由对交感神经系统的直接作用引起的,包括对心脏毒蕈碱M受体、突触前肾上腺素能受体的阻断以及肾上腺素能受体的间接激活。不幸的是,对于监测或治疗氯氮平所致心动过速尚无明确的指南。我们报告一例55岁难治性精神分裂症男性患者,开始使用氯氮平治疗,在治疗过程中出现持续性心动过速和右束支传导阻滞。尽管使用美托洛尔治疗,心动过速仍持续存在,患者需要转入重症监护病房。减少氯氮平剂量并加用辅助抗精神病药物(鲁拉西酮)使患者心率稳定。该病例强调了对使用氯氮平的患者进行持续体格检查和多学科治疗方法的必要性。该病例还表明,对于持续性心动过速患者,减少氯氮平剂量和联合使用抗精神病药物治疗可能避免停用氯氮平。